About US
Contact us
-
Eli Lilly completes Alnara acquisitionEli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of Alnara Pharmaceuticals, Inc., a privately-held company developing protein therapeutics for the treatment of2010/7/22
-
Genentech disappointed with FDA ODAC's recommendation against AvastinGenentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one2010/7/22
-
European marine and algae oil omega-3 ingredient market to grow at 10% CAGR to reach $525.6M in 2013The flood of scientific evidence on omega-3 eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility of polyunsaturated fatty acids (PUFAs) as vital functional i2010/7/21
-
NanoViricides presents study results of nanoviricides anti-Ebola agentsNanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company") reports that the results of the evaluation of several of its nanoviricides® anti-Ebola agents were presented July 17th at the Annual Meeting o2010/7/21
-
Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug AvandiaFero Industries, Inc. (FROI - OTCBB) (the "Company") is pleased to provide these comments regarding the recent Food and Drug Administration ("FDA") advisory panel recommendation concerning the Glaxo2010/7/21
-
Eisai's NDA for BANZEL Oral Suspension accepted for FDA reviewEisai Inc. (Headquarters: Woodcliff Lake, NJ; President and CEO: Lonnel Coats), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) today announced that the U.S.2010/7/20
-
FDA approves Mylan's ANDA for generic Catapres-TTSMylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applicati2010/7/20
-
FDA warns public over safety of stolen Advair Diskus inhalersThe FDA is warning the public that certain Advair Diskus inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies. The safety and effectiveness of the stolen inhalers2010/7/19
-
Warner Chilcott announces new FDA PDUFA date of October 24, 2010 for ActonelWarner Chilcott plc (Nasdaq: WCRX) announced today that it has received a communication from the U.S. Food & Drug Administration (FDA) related to its next generation Actonel® product (risedron2010/7/19
-
SFDA releases the second issue of 2010 National Medical Device Quality AnnouncementThe State Food and Drug Administration (SFDA) released the second issue of 2010 National Medical Device Quality Announcement on July 8,2010 and publicized the quality sampling and testing results of s2010/7/19